Delivery Order SPE2DR25D3015-SPE2DR26F4ER8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $21,295.85. This non-competitive, competitively awarded delivery order is scheduled for completion by August 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $7,736.36. This is a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and represents a non-competitive set-aside contract. The order will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $33,218.01 and an ultimate completion date of November 7, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $25,898.43, with completion scheduled for September 2, 2025. This non-set-aside competitive award is performed at AmerisourceBergen's Conshohocken, Pennsylvania location and represents a child delivery order under the company's larger indefinite delivery contract vehicle with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity, with a ceiling value of $7,604.31 and a firm fixed price contract type. This delivery order, which is non-set-aside and competitively awarded, is set to be completed by June 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $9,728.31. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is due for completion by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This competitively awarded contract, valued at $34,528.08, represents a firm fixed-price delivery order with performance completion scheduled for August 28, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $9,798.71. This competitive, non-set-aside award is structured as a firm fixed price delivery order with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $11,743.92, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4ER8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package, with a ceiling value of $5,192.09 and a firm fixed price structure. The delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The ultimate completion date for this delivery order is November 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's critical role as a pharmaceutical supplier to the federal medical supply chain, particularly for military and veteran healthcare systems. As one of the primary vendors under the DLA Troop Support Medical contract, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies across multiple therapeutic domains. The Jardiance prescription, commonly used in diabetes management, reflects the company's ongoing provision of essential medications to support federal healthcare operations and military readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 11/13/25 |